| Name |
Rapibloc 20 mg/2 ml koncentrat za otopinu za injekciju |
| Marketing Authorisation Number |
HR-H-555892936 |
| Active Substance |
landiololklorid |
| Composition |
svaki ml koncentrata sadrži 10 mg landiololklorida što odgovara 9,35 mg landiolola |
| Pharmaceutical Form |
koncentrat za otopinu za injekciju |
| Manufacturer |
AOP Orphan Pharmaceuticals GmbH, Beč, Austrija |
| Marketing Authorisation Holder |
Amomed Pharma GmbH, Leopold-Ungar-Platz 2, Beč, Austrija |
| Marketing Authorisation Date |
16.06.2021 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/20-02/131 |
| Registration Number |
381-12-01/154-21-02 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
ograničeni recept
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
C07AB14 |
| Marketing status |
nije stavljeno u promet |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
